What amount sold does Radiance Therapeutics, Inc. report in Form D filings?

The latest linked filings report $13.5M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Radiance Therapeutics, Inc.'s most recent SEC filing?

Radiance Therapeutics, Inc.'s most recent Form D filing was on 2023-06-29.

How many investors does Radiance Therapeutics, Inc. have?

The most recent Form D filing lists 51 investor(s).

What type of securities does Radiance Therapeutics, Inc. offer?

Radiance Therapeutics, Inc.'s SEC Form D filings indicate debt offerings.

Radiance Therapeutics, Inc.

CIK: 0001742457·Other Health Care·TUCSON, AZ·Corporation·Founded 2018

Reported Sold

$13,549,186

Total Filings

Identified Offerings

Last Filed

Jun 29, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Jun 29, 2023Form D/A — Amendment

Reported sold: $8,989,186 · Target: $10,500,000

Rule 506(b)·51 investors

Changed: Reported amount sold, Offering target

Jan 21, 2022Form D/A — Amendment

Reported sold: $4,289,000 · Target: $8,500,000

Rule 506(b)·51 investors

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions

Dec 29, 2020Form D — New notice

Reported sold: $1,017,475 · Target: $2,500,000

Rule 506(b)·44 investors

Jan 23, 2019Form D/A — Amendment

Reported sold: $3,525,000 · Target: $3,525,000

Rule 506(b)·45 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 23, 2019Form D — New notice

Reported sold: $1,025,000 · Target: $3,526,235

Rule 506(b)·2 investors

Aug 3, 2018Form D — New notice

Reported sold: $1,025,000 · Target: $3,000,000

Rule 506(b)·22 investors

Jun 4, 2018Form D — New notice

Reported sold: $10,000 · Target: $10,000

Rule 506(b)·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$129,573

Amendment Rate

43%

Latest reported sold across 4 identified offerings

$13,549,186

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Laurence John Marsteller

Related Person

Appears on 7 filings

Harry Allan George

Related Person

Appears on 5 filings

Peng Khaw

Related Person

Appears on 5 filings

Marc Sandroff

Related Person

Appears on 3 filings

Ken Abrahams

Related Person

Appears on 3 filings

G. Todd Silva

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 29, 2023	Amendment	$10,500,000	$8,989,186	51
Jan 21, 2022	Amendment	$8,500,000	$4,289,000	51
Dec 29, 2020	New	$2,500,000	$1,017,475	44
Jan 23, 2019	Amendment	$3,525,000	$3,525,000	45
Jan 23, 2019	New	$3,526,235	$1,025,000	2
Aug 3, 2018	New	$3,000,000	$1,025,000	22
Jun 4, 2018	New	$10,000	$10,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Captiox, LLC

Other Health Care

Offering target: $6,000,000

Filed Aug 14, 2026